Skip to main content
SpringerLink
Log in

Prognostic factors and the role of neprectomy in metastatic renal cell carcinoma

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

The objective of this study was to evaluate the prognostic factors and role of nephrectomy in metastatic renal cell carcinoma. We reviewed 62 cases of metastatic renal cell carcinoma (RCC) at presentation to document the factors influencing the survival and to evaluate the role of nephrectomy. Sex and age of the patients, size of the primary tumour, site and number of the metastases, nephrectomy, cell type and grade of the tumour and type of the medical treatment were analyzed as prognostic factors. The age and sex of the patients, cell type and type of the medical treatment did not appear to be significant predictors of prognosis. However, improved survival was correlated with tumours ≤7 cm in diameter, low grade tumours, metastasis limited to single organ and removal of the primary tumour. When these parameters were analyzed in a combined manner patients who had undergone nephrectomy showed consistently longer survival. We suggest that nephrectomy should be considered in all patients with metastatic RCC, as long as the morbidity of the operation is predicted to be acceptable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Patel, N. P., Lavengood, R. W.: Renal cell carcinoma: Natural history and results of treatment.J. Urol., 119, 722 (1978).

    PubMed  CAS  Google Scholar 

  2. deKernion, J. B., Lindner, A.: Treatment of advanced renal cell carcinoma.Prog. Clin. Biol. Res., 100, 641 (1982).

    PubMed  CAS  Google Scholar 

  3. Figlin, R. A., Abi-Aad, A. S., Belldegrun, A., deKernion, J. B.: The role of interferon and interleukin-2 in the immunotherapeutic approach to renal cell carcinoma.Sem. Oncol., 18 (Suppl.), 102 (1991).

    CAS  Google Scholar 

  4. Burke, H. B., Henson, D. E.: Criteria for prognostic factors and for an enhanced prognostic system.Cancer, 72, 3131 (1993).

    Article  PubMed  CAS  Google Scholar 

  5. Robson, C. J., Churchill, B. M., Anderson, W.: The results of radical nephrectomy for renal cell carcinoma.J. Urol., 101, 297 (1969).

    PubMed  CAS  Google Scholar 

  6. Cox, D. R.: Regression models and life tables.J. R. Stat. Soc. B., 34, 187 (1977).

    Google Scholar 

  7. Golimbu, M., Joshi, P., Sperber, A., Tessler, A., Al-Askari, S., Morales, P.: Renal cell carcinoma: Survival and prognostic factors.Urology, 27, 291 (1986).

    Article  PubMed  CAS  Google Scholar 

  8. Maldazys, J. D., deKernion, J. B.: Prognostic factors in metastatic renal cell carcinoma.J. Urol., 136, 376 (1986).

    PubMed  CAS  Google Scholar 

  9. Dal Bianco, M., Artibani, W., Bassi, P. F., Pescatori, W., Pagano, F.: Prognostic factors in renal cell carcinoma.Eur. Urol., 15, 73 (1988).

    Google Scholar 

  10. Naito, S., Kimiya, K., Sakamoto, N., Soejima, T., Ueda, T., Kumazawa, J., Osada, Y., Sagiyama, K., Ariyoshi, A.: Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.Urology, 37, 95 (1991).

    Article  PubMed  CAS  Google Scholar 

  11. Rackley, R., Novick, A., Klein, E., Bukowski, R., McLain, D., Goldfarb, D.: The impact of adjuvant nephrectomy on multimodality treatment of metastatic renal cell carcinoma.J. Urol., 152, 1399 (1994).

    PubMed  CAS  Google Scholar 

  12. Bennett, R. T., Lerner, S. E., Taub, H. C., Dutcher, J. P., Fleischmann, J.: Cytoreductive surgery for stage IV renal cell carcinoma.J. Urol., 154, 32 (1995).

    Article  PubMed  CAS  Google Scholar 

  13. Mani, S., Todd, M. B., Katz, K., Poo, W. J.: Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.J. Urol., 154, 35 (1995).

    Article  PubMed  CAS  Google Scholar 

  14. Montie, J. E., Stewart, B. H., Straffon, R. A., Banowsky, L. H. W., Hewitt, C. B., Montague, D. K.: The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma.J. Urol., 117, 272 (1977).

    PubMed  CAS  Google Scholar 

  15. Medeiros, L. J., Gelb, A. B., Weiss, L. M.: Renal cell carcinoma: Prognostic significance of morphologic parameters in 121 cases.Cancer, 61, 1639 (1988).

    Article  PubMed  CAS  Google Scholar 

  16. Fairlamb, D. J.: Spontaneous regression of metastases of renal cancer: A case report and of two cases including the first reported regression following irradiation of dominant and review of the world literature.Cancer, 47, 2102 (1981).

    Article  PubMed  CAS  Google Scholar 

  17. Montie, J. E.: Editorial: Prognostic factors for renal cell carcinoma.J. Urol., 152, 1397 (1994).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Hacettepe University Faculty of Medicine, Ankara, Turkey

    M. C. Uygur & H. Özen

  2. Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey

    A. Usubütün

Authors
  1. M. C. Uygur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Usubütün
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Özen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uygur, M.C., Usubütün, A. & Özen, H. Prognostic factors and the role of neprectomy in metastatic renal cell carcinoma. International Urology and Nephrology 30, 681–687 (1998). https://doi.org/10.1007/BF02564853

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02564853

Keywords

Search

Navigation